Stay updated with breaking news from Nasdaq Reta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research report released on Tuesday. The firm issued a sell rating on the stock. A number of other analysts have also recently weighed in on the stock. 888 restated a reiterates rating on shares of Reata Pharmaceuticals in a research note […]
StockNews.com assumed coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the stock. A number of other equities research analysts have also issued reports on the company. Jefferies Financial Group lowered Reata Pharmaceuticals from a buy rating to […]
StockNews.com initiated coverage on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research report report published on Saturday. The brokerage issued a sell rating on the stock. Several other research analysts have also commented on RETA. LADENBURG THALM/SH SH lowered shares of Reata Pharmaceuticals from a buy rating to a neutral rating and […]
Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Free Report) SVP Andrea Loewen sold 3,175 shares of Reata Pharmaceuticals stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $172.03, for a total value of $546,195.25. Following the sale, the senior vice president now directly owns 28,416 shares in the […]
Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Free Report)’s share price reached a new 52-week high on Tuesday . The stock traded as high as $172.15 and last traded at $172.11, with a volume of 341874 shares traded. The stock had previously closed at $172.05. Wall Street Analysts Forecast Growth Several equities research analysts have recently […]